Dow(US:DOW) Prnewswireยท2025-10-03 21:40Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, focusing on misleading statements regarding the company's financial health and performance during a specified class period [1][4]. Company Allegations - The lawsuit claims that Dow and its executives made false statements about the company's ability to handle macroeconomic challenges and maintain financial flexibility for dividends, which were overstated [4]. - It is alleged that Dow failed to disclose the true impact of competitive pressures, declining global sales, and product oversupply on its business [4]. Financial Performance - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00 due to ongoing weaknesses in key markets, leading to a stock price drop of over 3% [5]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline, missing estimates by $130 million [6]. - Following the disappointing earnings report, Dow's stock price fell by more than 17%, and the company announced a dividend cut from $0.70 to $0.35 per share to maintain financial flexibility amid challenging conditions [6]. Legal Process - Investors who purchased Dow securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [7]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect the ability to share in any potential recovery [7]. About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8].